A recently released study on the effectiveness of HPV-based versus cytology-based screening for cervical cancer showed that HPV-based screening provides 60–70% greater protection against invasive cervical carcinomas compared with cytology. The study included several years of follow-up of women in four randomized trials to investigate these outcomes. As the study authors write, “Data of large-scale randomized trials support initiation of HPV-based screening from age 30 years and extension of screening intervals to at least 5 years.
Read the study abstract here:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)62218-7/abstract